key: cord-1049969-rsfwni5w
authors: Chopra, Amit; Al-Tarbsheh, Ali Hani; Shah, Nidhi J.; Yaqoob, Hamid; Hu, Kurt; Feustel, Paul J.; Ortiz-Pacheco, Ronaldo; Patel, Kinner M.; Oweis, Jozef; Kozlova, Natalya; Zouridis, Spyridon; Ahmad, Sahar; Epelbaum, Oleg; Chong, Woon H.; Huggins, John T.; Saha, Biplab K.; Conuel, Edward; Chieng, Hau; Mullins, Jeanette; Bajaj, Divyansh; Shkolnik, Boris; Madisi, Nagendra; Judson, Marc A.
title: Pneumothorax in Critically ill Patients with COVID-19 Infection: Incidence, Clinical Characteristics and Outcomes in a Case Control Multicenter Study
date: 2021-05-13
journal: Respir Med
DOI: 10.1016/j.rmed.2021.106464
sha: 040ea8efa182993fbf5b82c291a66b8ca1204e9c
doc_id: 1049969
cord_uid: rsfwni5w

BACKGROUND: The clinical features and outcomes of mechanically ventilated patients with COVID-19 infection who develop a pneumothorax has not been rigorously described or compared to those who do not develop a pneumothorax. PURPOSE: To determine the incidence, clinical characteristics, and outcomes of critically ill patients with COVID-19 infection who developed pneumothorax. In addition, we compared the clinical characteristics and outcomes of mechanically ventilated patients who developed a pneumothorax with those who did not develop a pneumothorax. METHODS: This study was a multicenter retrospective analysis of all adult critically ill patients with COVID-19 infection who were admitted to intensive care units in 4 tertiary care centers in the United States. RESULTS: A total of 842 critically ill patients with COVID-19 infection were analyzed, out of which 594 (71%) were mechanically ventilated. The overall incidence of pneumothorax was 83/842 (10%), and 80/594 (13%) in those who were mechanically ventilated. As compared to mechanically ventilated patients in the non-pneumothorax group, mechanically ventilated patients in the pneumothorax group had worse respiratory parameters at the time of intubation (mean PaO(2):FiO(2) ratio 105 vs 150, P<0.001 and static respiratory system compliance: 30ml/cmH(2)O vs 39ml/cmH(2)O, P=0.01) and significantly higher in-hospital mortality (63% vs 49%, P=0.04). CONCLUSION: The overall incidence of pneumothorax mechanically ventilated patients with COVID-19 infection was 13%. Mechanically ventilated patients with COVID-19 infection who developed pneumothorax had worse gas exchange and respiratory mechanics at the time of intubation and had a higher mortality compared to those who did not develop pneumothorax.

Pneumothorax is a common complication of mechanical ventilation during critical illness, 1 and is an independent risk factor for mortality in this setting. [2] [3] [4] Pneumothorax is known to complicate diffuse pulmonary infections such as Pneumocystis jirovecii pneumonia and is associated with increased mortality in patients with Human Immunodeficiency Virus infection. 3, 5 Pneumothorax and other forms of barotrauma are common in patients with acute respiratory failure caused by two coronaviruses:

Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). 6, 7 Currently, the Coronavirus Disease 2019 (COVID- 19 ) pandemic has been a major cause of respiratory failure and death worldwide. Several case reports and series have described the occurrence of pneumothorax and pneumomediastinum in critically ill patients with COVID-19

pneumonia. [8] [9] [10] [11] [12] [13] Although a few recent studies have described the clinical features and outcomes of COVID-19 patients who developed barotrauma, including pneumothorax, 14, 15 the clinical features and outcomes of these patients have not been systematically compared to mechanically ventilated patients with COVID-19 who did not develop pneumothorax. In this multicenter analysis, we described the incidence, clinical characteristics, and outcomes of critically ill patients with COVID-19 who developed pneumothorax during their intensive care unit (ICU) stay. We also compared the clinical characteristics and outcomes of mechanically ventilated patients who developed a pneumothorax with those of mechanically ventilated patients who did not develop a pneumothorax. 

A total of 842 ICU patients with COVID-19 infection were admitted to the ICU at the 4 participating institutions during the study period. Of these, 594 (65%) required mechanical ventilation. A total of 85/842(10%) patients developed a pneumothorax, out of which 2 patients developed a pneumothorax after a central line insertion. After excluding these 2 iatrogenic pneumothoraxes, the overall incidence of pneumothorax in critically ill patients was 83/842 (9.8%) and in mechanically ventilated patients it was 80/594 (13.4%). The vast majority of patients who developed a pneumothorax were on mechanical ventilation (80/83, 96%). Of the three patients who developed a pneumothorax without mechanical ventilation, one patient was receiving non-invasive positive pressure ventilation, one patient was on high flow oxygen therapy, and one patient was receiving ECMO without mechanical ventilation. Remainder of the manuscript exclusively focuses on mechanically ventilated patients.

The baseline clinical characteristics of mechanically ventilated patients who developed a pneumothorax are shown in In the 80 mechanically ventilated COVID-19 patients who developed pneumothorax, the majority (60/80, 75%) of the patients had one episode of pneumothorax, however 20 patients have more than one pneumothorax. Out of these 20 patients with multiple pneumothoraces , 17 were contralateral and 3 were ipsilateral compared to the initial pneumothorax. In terms of the initial pneumothorax of each patient, the majority were right-sided (40/80, 50%%), followed by left-sided (23/80, 29%) and bilateral (17/80, 21%) . Clinical evidence of a tension pneumothorax was seen in 26/80 (32%) cases.

Concurrent pneumomediastinum was seen in 24/80 (30%) of cases. The majority 71/80(89%) of the patients received tube thoracostomy for the management of their pneumothorax, whereas the remainder 9/80 (11%) did not undergo any intervention.

In the 80 patients who were mechanically ventilated and developed a pneumothorax, the pneumothorax occurred at a mean of 10+12 days after initiation of mechanical ventilation. Table 2 describes the ventilator parameters recorded prior to detection of a pneumothorax. The PaO 2 /FiO2

(PF) was reduced (Mean= 114 +77), and static respiratory system compliance was low (Median= 24 + 15 ml/cmH 2 O). The mean tidal volume (TV) per kilogram (kg) of ideal body weight (IBW) recorded before the occurrence of pneumothorax was higher than the 6ml/kg recommended for ARDS patients (Mean= 6.9 +1.2). 16 

Respiratory support-N (%) (4) Peak pressure cm H2O (N=59) 34 (7) Plateau pressure cm H2O (N=18) 29 (7) Driving pressure cm H2O (N=18) 18 (6) Static pneumothorax and without pneumothorax. In this analysis, we assumed that those patients who were discharged were alive at 120 days after the hospital admission. Survival curves are not statistically different (log rank test; P=0.55), although survival at 120 days was statistically higher in nonpneumothorax group as compared to pneumothorax group (chi-square test; p=0.04). Overall , mechanically ventilated patients with pneumothorax had significantly higher in-hospital mortality as compared to patients without pneumothorax (63% vs 49%, P=0.04). Odds of in-hospital death were increased nearly two-fold (OR 1.75; CI: 1.01 to 3.03) in those who had a pneumothorax. infection. In this analysis, we assumed that those patients who were discharged were alive at 120 days after the hospital admission. Red dotted curve shows in-hospital survival of patients with pneumothorax and blue curve represent in-hospital survival of patients without pneumothorax. Survival curves are not statistically different (log rank test; P=0.55), although survival at 120 days was statistically higher in non-pneumothorax group as compared to pneumothorax group (chi-square test; p=0.04).

Mechanically ventilated patients who developed a pneumothorax had fewer mean ventilator-free days at day 28 (2 vs 9, P<0.001), ICU free days at day 28 (2 vs 6, P<0.001) and hospital free days at day 28 (1 vs 3, P<0.001) (Figure 2 and Table 4 ). Grey shaded rectangular box is the interquartile range (IQR, the 25 th to the 75 th percentile), the horizontal line within the box is the median, the solid square symbol is the mean.

There was no significant difference in the level of other inflammatory markers at the time of admission. In our analysis of 842 critically ill patients with COVID-19, the incidence of pneumothorax was 10%.

Pneumothoraces were almost exclusively found in patients who were mechanically ventilated where the rate of this complication was over 13%. Mechanically ventilated patients who developed a pneumothorax as compared to mechanically ventilated patients without a pneumothorax had greater severity of lung disease as reflected by poorer oxygenation, lower respiratory system compliance, and higher plateau pressure at the time of intubation. Mechanically ventilated patients with a pneumothorax had a higher in-hospital mortality than mechanically ventilated patients who did not develop a pneumothorax (63% vs 49%, P=0.04).

The present study is the largest to date describing the incidence, patient characteristics, and 14 However, there is concern for selection bias in the UK study as cases were collected based on the authors' recall and collaboration via internet media platforms such as Twitter. Moreover, fewer than half (44%) of the patients in that study were mechanically ventilated and one third of the patients were not intubated. Another recent study compared the outcome of non-intubated patients with COVID-19 infection who presented to the ED with a pneumothorax to without a pneumothorax. Patients with pneumothorax were found to have a 4fold increase in risk of death as compared to patients who did not have pneumothorax. 19 pneumothorax as compared to those who did not.

It is likely that pneumothorax is a marker of more severe COVID-19 induced lung disease. This conjecture is supported by our findings that patients with pneumothorax had inferior gas exchange and respiratory system compliance than their counterparts without pneumothorax. Recent radiological studies have shown that COVID-19 infection is associated with architectural distortion of lung parenchyma with cyst formation 21, 22 , which may predispose the lung to the development of

pneumothorax. An additional cause of pneumothorax in patients COVID-19 infection likely occurs because of barotrauma induced from excessive positive pressure ventilation imposed on a lung that is already structurally vulnerable. This is a known occurrence in mechanically ventilated patients with other forms of ARDS. Support for this cause of pneumothorax in our cohort includes that patients who developed pneumothoraces were also receiving higher-than-recommended TV at the time of intubation as well as before the occurrence of pneumothorax. Such iatrogenic lung injury from suboptimal ventilator management may have played a role in the development of pneumothorax in some patients.

Our study had several limitations. First, neither COVID-19 management nor ventilator management were standardized among the 4 participating centers. Second, the radiographic data were not analyzed in detail. Third, this is a retrospective study, so we were not able to record ventilator parameters in real time. Finally, the COVID-19 pandemic appears to have changed significantly over time in terms of available therapy and outcomes. 23, 24 It is possible that our results, including the severity of lung disease and mortality, cannot be extrapolated to future critically ill COVID-19 infected patients. Nevertheless, we suspect that our comparison between patients with and without a pneumothorax will remain valid.

In summary, we found that 13% of critically ill patients with COVID-19 infection who were mechanically ventilated developed a pneumothorax. Patients who developed pneumothorax had evidence of severe lung injury with poor gas exchange and low respiratory system compliance. Those who developed pneumothorax appear to be receiving higher tidal volumes per kilogram of IBW as compared to those who did not develop a pneumothorax and these tidal volumes were above those recommended for ARDS. Hospital length of stay and mortality was higher in those who developed pneumothorax compared to those who did not. These results suggest that the development of a pneumothorax in a mechanically ventilated COVID-19 infected patient is a poor prognostic sign.

Although we did not establish causation, these results also suggest that strict attention to accepted ventilatory strategies for ARDS may be important in minimizing the likelihood of barotrauma and poor outcome in these patients.

There is a need for a prospective study examining the development of pneumothorax in mechanically ventilated patients with COVID-19 pneumonia. With careful attention to clinical, physiological and radiographic parameters, such a study may improve our ability to identify mechanically ventilated COVID-19 patients at high of development of a pneumothorax. Furthermore, such a study may provide insights on how to optimally manage mechanical ventilation in these patients.

MAJ: received institution grant support from Mallinckrodt pharmaceuticals. JH: Consultant/Advisory Boards: IBIOS

PJF: Scientific advisor with shares in Penrose TherapeuTx, LLC. The remaining

AC is the guarantor of the paper and takes responsibility for the integrity of the work

Pneumothorax in the critically ill patient

Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study

Pneumocystis carinii pneumonia requiring intensive care management: survival and prognostic study in 110 patients with human immunodeficiency virus

Lung structure and function in different stages of severe adult respiratory distress syndrome

Etiology of spontaneous pneumothorax in 105 HIV-infected patients without highly active antiretroviral therapy

Acute Middle East Respiratory Syndrome Coronavirus: Temporal Lung Changes Observed on the Chest Radiographs of 55 Patients

Severe acute respiratory syndrome complicated by spontaneous pneumothorax

Does COVID-19 Increase the Risk for Spontaneous Pneumothorax?

Tension pneumothorax in a patient with COVID-19

Pneumothorax in patients with prior or current COVID-19 pneumonia

Spontaneous pneumomediastinum in an elderly COVID-19 patient: A case report

Spontaneous subcutaneous emphysema and pneumomediastinum in non-intubated patients with COVID-19

COVID-19 with spontaneous pneumomediastinum

COVID-19 and Pneumothorax: A Multicentre Retrospective Case Series. The European respiratory journal

Increased Incidence of Barotrauma in Patients with COVID-19 on Invasive Mechanical Ventilation

An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice

Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome. American journal of respiratory and critical care medicine

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Analysis of 92 deceased patients with COVID-19

Frequency, risk factors, clinical characteristics and outcomes of spontaneous pneumothorax in patients with Covid-19: A case-control, emergency medicine-based multicenter study

Compliance Phenotypes in Early Acute Respiratory Distress Syndrome before the COVID-19 Pandemic. American journal of respiratory and critical care medicine

Evolution of chest CT manifestations of COVID-19: a longitudinal study

COVID-19 with cystic features on computed tomography: A case report

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

Covid-19: Remdesivir has little or no impact on survival, WHO trial shows